LifeCare PCA Infusion System 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Hospira 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2012-09-11
  • 사례 출판 날짜
    2012-09-11
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: hospira lifecare pca infusion system the medicines and healthcare products regulatory agency (mhra), united kingdom posted a field safety notice concerning lifecare pca infusion system, manufactured by hospira, inc. the manufacturer has received customer reports related to improper use of the slide clamp when the syringe (vial) is manipulated, or when stopping the infusion during delivery of medication. failure to close the slide clamp whilst manipulating the syringe (vial) or stopping the infusion, may result in an over delivery of the medication being infused which has the potential to cause a life threatening/critical injury to the patient. furthermore, the manufacturer advised users to follow the labelled instructions for the correct use of the slide clamp when manipulating the syringe (vial) or when stopping infusion during delivery of fluids. hospira is in the process of creating cautionary labels for the pca device, which will alert clinicians to close the slide clamp prior to handling the pca vial and to open the slide clamp before starting therapy. the manufacturer is also investigating whether a design improvement is feasible to further mitigate this risk. for details, please refer to the following mhra website: http://www.Mhra.Gov.Uk/safetyinformation/ safetywarningsalertsandrecalls/fieldsafetynotices/con184398 if you are in possession of the product, please contact your supplier for necessary actions. posted on 11 september 2012.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Hospira LifeCare PCA Infusion System
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    DH